Skip to main content
SpringerLink
Log in

Long-term follow-up of young patients with essential thrombocythemia treated with pipobroman

  • Rapid Communication
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Tefferi A, Solberg LA, Silverstein MN (2000) A clinical update in polycythemia vera and essential thrombocythemia. Am J Med 109:141–149

    CAS  PubMed  Google Scholar 

  2. Storen EC, Tefferi A (2001) Long-term use of anagrelide in young patients with essential thrombocythemia. Blood 97:863–866

    CAS  PubMed  Google Scholar 

  3. Finazzi G, Ruggeri M, Rodeghiero F et al (2003) Efficacy and safety of long-term use of hydroxyurea in young patients with essential thrombocythemia and a high risk of thrombosis [letter]. Blood 101:3749

    Article  CAS  Google Scholar 

  4. Passamonti F, Malabarba L, Orlandi E et al (2002) Pipobroman is safe and effective treatment for patients with essential thrombocythemia at high risk of thrombosis. Br J Haematol 116:855–861

    Article  CAS  PubMed  Google Scholar 

  5. De Sanctis V, Mazzucconi MG, Spadea A et al (2003) Long-term evaluation of 164 patients with essential thrombocythaemia treated with pipobroman: occurrence of leukaemic evolution. Br J Haematol 123:517–521

    Article  PubMed  Google Scholar 

  6. Murphy S, Iland H, Rosenthal et al (1986) Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Semin Hematol 23:177–182

    CAS  PubMed  Google Scholar 

  7. Murphy S, Peterson P, Iland H et al (1997) Experience of Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Semin Hematol 34:29–39

    CAS  Google Scholar 

  8. Monto RW, Ten Pas A, Battle JD, Rohn RJ, Louis J, Louis NB (1964) A-8130 in Polycythemia J Am Med Assoc 190:97–100

    Google Scholar 

  9. Stein RJ (1960) Antitumor properties of N,N′-bis (3-bromopropionil) and N, N′-bis-(3-chloropropionil) piperazine. J Lab Clin Med 56:949–951

    Google Scholar 

  10. Ernst E, Hammerschmidt DE, Bagge U et al (1987) Leukocytes and the risk of ischemic diseases. J Am Med Assoc 257:2318–2324

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology, IRCCS Policlinico San Matteo, University of Pavia, Viale Golgi 19, 27100, Pavia, Italy

    Francesco Passamonti, Elisa Rumi, Lucia Malabarba, Luca Arcaini, Ester Orlandi, Ercole Brusamolino, Cristiana Pascutto, Mario Cazzola & Mario Lazzarino

Authors
  1. Francesco Passamonti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elisa Rumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lucia Malabarba
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Luca Arcaini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ester Orlandi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ercole Brusamolino
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Cristiana Pascutto
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mario Cazzola
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Mario Lazzarino
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francesco Passamonti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Passamonti, F., Rumi, E., Malabarba, L. et al. Long-term follow-up of young patients with essential thrombocythemia treated with pipobroman. Ann Hematol 83, 495–497 (2004). https://doi.org/10.1007/s00277-004-0882-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-004-0882-7

Keywords

Search

Navigation